FRA:BSN - Deutsche Boerse Ag - FR0000120644 - Common Stock - Currency: EUR
FRA:BSN (6/18/2025, 7:00:00 PM)
71.96
+0.2 (+0.28%)
The current stock price of BSN.DE is 71.96 EUR. In the past month the price decreased by -4.94%. In the past year, price increased by 23.18%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
NESR.DE | NESTLE SA-REG | 17.43 | 227.71B | ||
ORK.OL | ORKLA ASA | 16.41 | 108.96B | ||
MOWI.OL | MOWI ASA | 13.6 | 96.80B | ||
KTF.DE | MONDELEZ INTERNATIONAL INC-A | 20.58 | 75.14B | ||
SALM.OL | SALMAR ASA | 23.03 | 57.78B | ||
BN.PA | DANONE | 19.72 | 48.76B | ||
LSG.OL | LEROY SEAFOOD GROUP ASA | 6.27 | 26.67B | ||
KHNZ.DE | KRAFT HEINZ CO/THE | 8.61 | 26.51B | ||
BAKKA.OL | BAKKAFROST P/F | 18.89 | 26.13B | ||
GRM.DE | GENERAL MILLS INC | 11.86 | 25.26B | ||
KEL.DE | KELLANOVA | 21.41 | 24.14B | ||
AUSS.OL | AUSTEVOLL SEAFOOD ASA | 6.59 | 18.45B |
Danone SA engages in the food processing industry. The company is headquartered in Paris, Ile-De-France and currently employs 89,528 full-time employees. The company operates through four segments: Essential Dairy and Plant-Based Products (EDP), Waters and Specialized Nutrition, including Early Life Nutrition and Medical Nutrition. EDP produces and distributes fresh fermented dairy products and other dairy specialties, plant-based products and beverages, coffee creamers and organic products; Waters sells bottled water and water sold in small and large containers; Early Life Nutrition offers baby formula (infant milk formula, follow-on milk, growing up milks), milk and fruit-based desserts, cereals, jars of baby food and ready-made baby food; Advanced Medical Nutrition offers adult or pediatric clinical nutrition products to be taken orally or through a tube in the event of malnutrition related to illness or other causes. The Company’s brands portfolio includes Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia, and others.
DANONE
17, boulevard Haussmann
Paris ILE-DE-FRANCE FR
Employees: 89528
Phone: 33144352020
The current stock price of BSN.DE is 71.96 EUR. The price increased by 0.28% in the last trading session.
The exchange symbol of DANONE is BSN and it is listed on the Deutsche Boerse Ag exchange.
BSN.DE stock is listed on the Deutsche Boerse Ag exchange.
32 analysts have analysed BSN.DE and the average price target is 75.19 EUR. This implies a price increase of 4.49% is expected in the next year compared to the current price of 71.96. Check the DANONE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DANONE (BSN.DE) has a market capitalization of 49.01B EUR. This makes BSN.DE a Large Cap stock.
DANONE (BSN.DE) currently has 89528 employees.
DANONE (BSN.DE) has a support level at 71.4 and a resistance level at 73.03. Check the full technical report for a detailed analysis of BSN.DE support and resistance levels.
The Revenue of DANONE (BSN.DE) is expected to grow by 1.76% in the next year. Check the estimates tab for more information on the BSN.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DANONE (BSN.DE) has a dividend yield of 2.94%. The yearly dividend amount is currently 2.1. Check the full fundamental report for a detailed analysis of BSN.DE dividend history, reliability and sustainability.
DANONE (BSN.DE) will report earnings on 2025-07-30.
The PE ratio for DANONE (BSN.DE) is 19.82. This is based on the reported non-GAAP earnings per share of 3.63 and the current share price of 71.96 EUR. Check the full fundamental report for a full analysis of the valuation metrics for BSN.DE.
ChartMill assigns a technical rating of 6 / 10 to BSN.DE. When comparing the yearly performance of all stocks, BSN.DE is one of the better performing stocks in the market, outperforming 83.25% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to BSN.DE. While BSN.DE has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months BSN.DE reported a non-GAAP Earnings per Share(EPS) of 3.63. The EPS increased by 2.54% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 7.37% | ||
ROA | 4.46% | ||
ROE | 11.34% | ||
Debt/Equity | 0.66 |
ChartMill assigns a Buy % Consensus number of 73% to BSN.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 7.96% and a revenue growth 1.76% for BSN.DE